Gatchel Jennifer R, Donovan Nancy J, Locascio Joseph J, Schultz Aaron P, Becker J Alex, Chhatwal Jasmeer, Papp Kathryn V, Amariglio Rebecca E, Rentz Dorene M, Blacker Deborah, Sperling Reisa A, Johnson Keith A, Marshall Gad A
Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Division of Geriatric Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA, USA.
J Alzheimers Dis. 2017;59(3):975-985. doi: 10.3233/JAD-170001.
Depressive symptoms are common in older adults and associated with increased morbidity and cognitive decline. These symptoms occur during preclinical and prodromal stages of Alzheimer's disease (AD), but their relationship to tau, one of the main AD proteinopathies, is poorly understood.
The objective of this study was to investigate the cross-sectional association between depressive symptoms and cerebral tau [18F T807 (also known as 18F-AV-1451) tau positron emission tomography (PET) imaging] in cognitively normal (CN) older adults.
We measured depressive symptoms using the Geriatric Depression Scale (GDS), and in vivo cerebral tau using T807 PET in 111 CN older adults. We employed general linear regression models to evaluate the relationship of GDS score regressed on entorhinal cortex (EC) or inferior temporal (IT) tau in separate backward elimination models. Other predictors included age, sex, and in secondary analyses, amyloid (Pittsburgh Compound B PET).
Higher GDS was significantly associated with greater IT tau (partial r = 0.188, p = 0.050) and marginally associated with greater EC tau (partial r = 0.183, p = 0.055). In additional analyses including both linear and quadratic age terms, we found a significant U-shaped relation of GDS to age (p = 0.001).
Results suggest that IT and EC tau are modestly associated with depressive symptoms in CN older adults. Findings suggest a link between depressive symptoms and tau-mediated neurodegeneration in a region vulnerable in AD. Future longitudinal studies examining the association of more severe depressive symptoms and cerebral tau accumulation are needed to substantiate this finding and to guide prevention and treatment in AD.
抑郁症状在老年人中很常见,且与发病率增加和认知衰退相关。这些症状出现在阿尔茨海默病(AD)的临床前期和前驱期,但它们与AD主要蛋白病变之一的tau蛋白之间的关系尚不清楚。
本研究的目的是调查认知正常(CN)的老年人抑郁症状与脑tau蛋白[18F T807(也称为18F-AV-1451)tau正电子发射断层扫描(PET)成像]之间的横断面关联。
我们使用老年抑郁量表(GDS)测量了111名CN老年人的抑郁症状,并使用T807 PET测量了其活体脑tau蛋白。我们采用一般线性回归模型,在单独的向后消除模型中评估GDS评分与内嗅皮质(EC)或颞下回(IT)tau蛋白的关系。其他预测因素包括年龄、性别,在二次分析中还包括淀粉样蛋白(匹兹堡化合物B PET)。
较高的GDS与较高的IT tau蛋白显著相关(偏相关系数r = 0.188,p = 0.050),与较高的EC tau蛋白有边缘性关联(偏相关系数r = 0.183,p = 0.055)。在包括线性和二次年龄项的额外分析中,我们发现GDS与年龄呈显著的U形关系(p = 0.001)。
结果表明,IT和EC tau蛋白与CN老年人的抑郁症状有适度关联。研究结果表明,在AD易损区域,抑郁症状与tau介导的神经退行性变之间存在联系。未来需要进行纵向研究,以检验更严重的抑郁症状与脑tau蛋白积累之间的关联,以证实这一发现并指导AD的预防和治疗。